Skip to main content
CA

Cantargia

Lund, Sweden
Last funding
$13.2M
Post-IPO EquityMay 2026

Cantargia develops a therapy for the treatment of cancer by targeting a unique cell-surface receptor on malignant stem cells.

Backed bySunstone Life Science VenturesFenja CapitalLubio Science

About Cantargia

How much funding has Cantargia raised?

Cantargia has raised $13.2M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in May 2026.

Who are Cantargia's investors?

Cantargia's investors include Sunstone Life Science Ventures, Fenja Capital, Lubio Science.

Where is Cantargia headquartered?

Cantargia is headquartered in Lund, Sweden.

What does Cantargia do?

Cantargia develops a therapy for the treatment of cancer by targeting a unique cell-surface receptor on malignant stem cells.

What stage is Cantargia at?

Cantargia is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Cantargia — Funding & Investors." VCBacked, May 21, 2026, https://www.vcbacked.co/company/cantargia. Accessed November 13, 2026.
APA
VCBacked. (2026). Cantargia — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/cantargia
Wikipedia (cite web)
{{cite web |title=Cantargia — Funding & Investors |url=https://www.vcbacked.co/company/cantargia |website=VCBacked |access-date=November 13, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Cantargia? Request a listing update

Founder contacts
m***@cantargia.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →